ModelEdge
Trillium Therapeutics Inc.
0001616212
Filing type
8-K
Filing date
Nov 16, 2021
Updated
Nov 17, 2021 ยท 2:28 AM

Filing

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events

Exhibits

EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other EventsGRAPHICGraphic